DAY 1 (Tuesday, September 15, 2009)
|
General Session:
|
7:15-8:15
|
Registration & Networking Breakfast in Exhibition Hall
__________________________________________________________________________________________________________________________________
|
8:15-8:30
|
Chairpersons’ Opening Remarks
__________________________________________________________________________________________________________________________________
|
8:30-9:15
|
Who Moved My Cheese? –The Biopharmaceutical Industry Can Adapt To Change For A Brighter Future
__________________________________________________________________________________________________________________________________
|
9:15-10:00
|
Follow-on Biologics: Political Landscape and Key Provisions
__________________________________________________________________________________________________________________________________
|
10:00-11:00
|
Networking & Refreshments in Exhibition Hall
__________________________________________________________________________________________________________________________________
|
11:00-12:00
|
Keynote Panel: Reaction/Response to Keynote Presentations
__________________________________________________________________________________________________________________________________
|
12:00-12:30
|
Managed Markets, Formularies & You: The Use of Competitive Intelligence to Understand the Most Influential Growth Sales and Marketing Category
__________________________________________________________________________________________________________________________________
|
12:30-2:00
|
Networking Luncheon Presentation: How CI Can Survive and Thrive In Turbulent Times
_________________________________________________________________________________________________
|
2:00-3:00
|
Networking Roundtables/Discussion (Led by an expert at each table placed throughout exhibition hall. Participants may freely move from one table to another in this open space environment.)
|
| |
ROUNDTABLE 1:
|
Customized Healthcare in a Comparative Effectiveness World
|
| |
ROUNDTABLE 2:
|
Conducting CI in Emerging Markets
|
| |
ROUNDTABLE 3:
|
Technology Roadmapping
|
| |
ROUNDTABLE 4:
|
Landscape of Chinese Pharma and Conducting BI/CI in China
|
| |
ROUNDTABLE 5:
|
Identifying how CI can best support R&D
|
| |
ROUNDTABLE 6:
|
CMO Trends and Differences Between CMO Intelligence vs. Big Pharma/Biotech
|
| |
ROUNDTABLE 7:
|
CI in M&A Strategy
|
| |
ROUNDTABLE 8:
|
Oncology Commercialization Strategies
|
| |
ROUNDTABLE 9:
|
How to Effectively Analyze your Competitor’s Clinical Trials
|
| |
ROUNDTABLE 10:
|
Identifying and Assessing Novel Approaches to CI
|
| |
ROUNDTABLE 11:
|
Developing a Counter-Intelligence System
|
| |
ROUNDTABLE 12:
|
Optimizing your Time and Resources with an External CI-Support System
|
3:00-4:00
|
Networking & Refreshments in Exhibition Hall
|